Biogen Inc. (BIIB) Financial Statements (2024 and earlier)

Company Profile

Business Address 225 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,0285,1121,5411,9062,9141,225
Cash and cash equivalents6112,848 6272,9141,225
Short-term investments4172,2651,5411,279  
Receivables1,6641,7051,5491,9141,8811,959
Inventory, net of allowances, customer advances and progress billings2,5271,3441,3521,069804930
Inventory2,5271,3441,3521,069804930
Prepaid expense      271
Other current assets1,1821,418741881631688
Other undisclosed current assets4582122,6741,1182,1522,569
Total current assets:6,8599,7917,8576,8878,3827,641
Noncurrent Assets
Inventory, Noncurrent      7
Operating lease, right-of-use asset420404375433427
Property, plant and equipment3,3103,2993,4163,4123,2473,601
Long-term investments and receivables  706892772  
Long-term investments  706892772  
Intangible assets, net (including goodwill)14,5827,5997,9828,8469,2858,826
Goodwill6,2195,7495,7615,7625,7585,706
Intangible assets, net (excluding goodwill)8,3631,8502,2213,0843,5273,120
Deferred income tax assets9291,2261,4151,370 
Other noncurrent assets7451,5291,9402,8991,2531,691
Deferred tax assets, net2,154
Other undisclosed noncurrent assets     4,6401,369
Total noncurrent assets:19,98614,76316,02117,73218,85317,648
TOTAL ASSETS:26,84524,55423,87724,61927,23425,289
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities661751764597602434
Taxes payable1751427164
Accounts payable403492589455531371
Accrued liabilities257260    
Debt150 999 1,496 
Other liabilities2,6242,5212,5353,1452,7662,861
Total current liabilities:3,4343,2734,2983,7424,8643,295
Noncurrent Liabilities
Long-term debt and lease obligation 6,7886,5673304026,413 
Long-term debt, excluding current maturities 6,7886,567  6,000 
Liabilities, other than long-term debt1,8231,6122,0152,3622,1523,026
Accounts payable and accrued liabilities    803 
Deferred tax liabilities, net1,636
Deferred income tax liabilities6423356951,033 
Other liabilities7819441,3211,3301,3491,389
Operating lease, liability400333330402413
Other undisclosed noncurrent liabilities (286)6,2747,4264675,937
Total noncurrent liabilities:8,6117,8938,61910,1919,0318,962
Total liabilities:12,04511,16612,91813,93313,89512,257
Equity
Equity, attributable to parent, including:14,79913,39810,89610,70013,34313,040
Common stock 00000
Treasury stock, value(2,977)(2,977)(2,977)(2,977)(2,977)(2,977)
Additional paid in capital3037368   
Accumulated other comprehensive loss(154)(165)(107)(299)(135)(240)
Retained earnings17,62816,46713,91213,97616,45516,257
Other undisclosed equity, attributable to parent 0     
Equity, attributable to noncontrolling interest  (10)64(14)(4)(8)
Total equity:14,79913,38810,96010,68613,33913,032
TOTAL LIABILITIES AND EQUITY:26,84524,55423,87724,61927,23425,289

Income Statement (P&L) ($ in millions)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues9,83610,17310,98213,44514,37813,453
Cost of revenue(3,308)(2,320)(2,948)(2,417)(2,623)(2,736)
Cost of goods and services sold(2,533)(2,278)(2,110)(1,805)(1,955)(1,816)
Other undisclosed gross profit    611668920
Gross profit:6,5277,8548,03411,63912,42311,637
Operating expenses(5,231)(4,262)(5,194)(6,478)(4,712)(4,828)
Other operating expense, net
(Other undisclosed Other operating expense, net)
      
Other undisclosed operating income (loss)   (611)(668)(920)
Operating income:1,2973,5922,8414,5507,0435,889
Nonoperating income (expense)(316)108(1,096)4978311
Investment income, nonoperating 2771,5951142120113
Gain (loss), foreign currency transaction, before tax 5036(22)(11)(7)(10)
Other nonoperating income (expense) 410(6)3(47)(11)
Interest and debt expense(247)(247)(254)(223)(187)(201)
Other undisclosed income from continuing operations before equity method investments, income taxes562138254223187201
Income from continuing operations before equity method investments, income taxes:1,2973,5921,7455,0487,1265,900
Income (loss) from equity method investments  3353(79) 
Other undisclosed income from continuing operations before income taxes      
Income from continuing operations before income taxes:1,2973,5941,7805,0517,0475,900
Income tax expense(135)(633)(53)(992)(1,158)(1,426)
Income from continuing operations:1,1622,9621,7284,0595,8894,474
Income before gain (loss) on sale of properties:1,7284,0595,8894,474
Other undisclosed net income    2  
Net income:1,1622,9621,7284,0615,8894,474
Net income (loss) attributable to noncontrolling interest(0)85(172)(60) (43)
Net income available to common stockholders, diluted:1,1613,0471,5564,0015,8894,431

Comprehensive Income ($ in millions)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income:1,1622,9621,7284,0615,8894,474
Other comprehensive income (loss)11(58)193(163)10576
Comprehensive income:1,1732,9031,9213,8985,9934,550
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(0)85(172)(61)0(43)
Comprehensive income, net of tax, attributable to parent:1,1722,9891,7483,8375,9944,507

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: